Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
lanadelumab
Description:
A monoclonal antibody drug that inhibits plasma kallikrein and is used to prevent attacks of hereditary angioedema.
Primary topic:
Coagulation, Bradykinin, Polyphosphates, and Angioedema (94%)
Related topic:
Coagulation, Bradykinin, Polyphosphates, and Angioedema (94%)
Wikidata ID:
wiki/Q25326708
OpenAlex ID:
keywords/lanadelumab
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial
2018
·
Aleena Banerji
, Marc A. Riedl
, et al.
·
JAMA
·
355
PDF
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis
2017
·
Aleena Banerji
, Paula Busse
, et al.
·
New England Journal of Medicine
·
188
PDF
Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
2021
·
Aleena Banerji
, Jonathan A. Bernstein
, et al.
·
Allergy
·
115
Hereditary and acquired angioedema
2019
·
Gayatri Patel
, Jacqueline A. Pongracic
·
Allergy and Asthma Proceedings
·
96
Treatment of Hereditary Angioedema
2021
·
T Caballero
·
Journal of Investigational Allergology and Clinical Immunology
·
95
PDF
Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study
2020
·
William R. Lumry
, Karsten Weller
, et al.
·
Allergy
·
76
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
2020
·
Marc A. Riedl
, Marcus Maurer
, et al.
·
Allergy
·
64
PDF
Lanadelumab Efficacy, Safety, and Injection Interval Extension in HAE: A Real-Life Study
2021
·
Thomas Buttgereit
, Carolina Vera
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
52
Current medical management of hereditary angioedema
2020
·
Marc A. Riedl
, Aleena Banerji
, et al.
·
Annals of Allergy Asthma & Immunology
·
51
A lesson from a saboteur: High‐MW kininogen impact in coronavirus‐induced disease 2019
2020
·
Chiara Colarusso
, Michela Terlizzi
, et al.
·
British Journal of Pharmacology
·
41
PDF
Interventions for the long-term prevention of hereditary angioedema attacks
2022
·
Nicole Beard
, Michael Frese
, et al.
·
Cochrane Database of Systematic Reviews
·
39
Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study
2023
·
Marcus Maurer
, William R. Lumry
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
37
PDF
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
2017
·
Marc A. Riedl
, Jonathan A. Bernstein
, et al.
·
Clinical and Translational Allergy
·
37
PDF
Hereditary Angioedema Attacks in Patients Receiving Long-Term Prophylaxis: A Systematic Review
2024
·
Hilary J. Longhurst
, Mauro Cancian
, et al.
·
Clinical Reviews in Allergy & Immunology
·
34
PDF
Lanadelumab: First Global Approval
2018
·
Yahiya Y. Syed
·
Drugs
·
34
Treatment of hereditary angioedema—single or multiple pathways to the rescue
2022
·
Anna Valerieva
, Hilary J. Longhurst
·
Frontiers in Allergy
·
33
PDF
Real-World Effectiveness of Lanadelumab in Hereditary Angioedema: Multicountry INTEGRATED Observational Study
2024
·
Markus Magerl
, Laurence Bouillet
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
32
PDF
Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
2020
·
François Marceau
, Georges E. Rivard
, et al.
·
Frontiers in Medicine
·
31
PDF
Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema
2023
·
William R. Lumry
, Marcus Maurer
, et al.
·
Annals of Allergy Asthma & Immunology
·
30
PDF
Hereditary angioedema in children and adolescents – A consensus update on therapeutic strategies for German‐speaking countries
2020
·
Volker Wahn
, Werner Aberer
, et al.
·
Pediatric Allergy and Immunology
·
30
PDF
Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies
2018
·
Paula J. Busse
, Henriette Farkas
, et al.
·
BioDrugs
·
30
PDF
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor
2022
·
Douglas H. Jones
, Priya Bansal
, et al.
·
World Allergy Organization Journal
·
29
PDF
Prospective Analysis in Patients With HAE Under Prophylaxis With Lanadelumab: A Real-life Experience
2020
·
Janina Hahn
, Susanne Trainotti
, et al.
·
Journal of Drugs in Dermatology
·
28
The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center
2024
·
Thomas Buttgereit
, Carolina Vera Ayala
, et al.
·
Frontiers in Immunology
·
27
Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate
2023
·
Marc A. Riedl
, David R. Hinds
, et al.
·
Allergy and Asthma Proceedings
·
26
Show more works
View as search
Works count:
438
Citation count:
2,805
Year
Topic
Type